Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

 Hylenex Recombinant (Hyaluronidase) Human Injection
Company:  Halozyme Therapeutics, Inc.
Application No.:  021859
Approval Date: 12/02/2005


Date created: January 032006

Updated: 052017

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.